Myeloma | Tumor

CURE’s myeloma page is a go-to resource for oncology news and updates in the world of myeloma Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in myeloma.

Cancer-Related Fatigue May Be a Major Symptom in Multiple Myeloma

October 25th 2018

A recent study found that fatigue reported among newly diagnosed patients with multiple myeloma may predict survival outcomes.

Revlimid Shows Promise for Smoldering Multiple Myeloma

October 25th 2018

Preliminary findings showed that Revlimid (lenalidomide) significantly prolonged progression-free survival compared with observation in patients with smoldering multiple myeloma.

FDA Grants Priority Review to Selinexor for Multiple Myeloma

October 8th 2018

The Food and Drug Administration has granted a priority review to a new drug application for selinexor (KPT-330) for the treatment of patients with penta-refractory multiple myeloma.

FDA Approves Once-Weekly Kyprolis Regimen for Myeloma

October 1st 2018

The Food and Drug Admnistration has approved a once-weekly dosing option of Kyprolis (carfilzomib) to use in combination with dexamethasone for patients with relapsed/refractory multiple myeloma.

CURE New Issue Alert: Hematology Special Issue

September 20th 2018

September is Blood Cancer Awareness month and CURE’s latest issue is dedicated to these diseases. And we have a sneak peek at what’s inside:

Myeloma Link: Empowering African Americans

September 18th 2018

Walking Through 'Fire and Ice' for a Cure

September 17th 2018

A 16-member team, including five patients with multiple myeloma, hiked through Iceland to raise money for disease research in hopes of finding a cure.

Taking a Shot to Treat Blood Cancers

September 13th 2018

Injectable forms of medication may benefit patients with blood cancers.

Elderly Patients With Myeloma Still Candidates for Transplant

September 10th 2018

Previously, there were concerns that older patients would not be able to handle the toxicities of the procedure, or that their stem cells, which are older, would not work as well. But that proved to not be the case.

FDA Grants Empliciti Combination a Priority Review for Myeloma Treatment

August 23rd 2018

The FDA has granted a priority review to a supplemental biologics license application (sBLA) for Empliciti (elotuzumab) for use in combination with Pomalyst (pomalidomide) and low-dose dexamethasone (EPd) for the treatment of patients with relapsed/refractory multiple myeloma following two or more prior therapies, including Revlimid (lenalidomide) and a proteasome inhibitor (PI).

Comments From Our Readers on the Summer 2018 Issue

August 17th 2018

See what CURE readers have to say about our previous issues.

Running the Marathon Called Cancer

August 16th 2018

In this week’s episode of CURE Talks Cancer, we spoke with Ethan Hawes about his experience as a 22-year-old diagnosed with multiple myeloma, and his advice for others going through a similar journey.

Pre-Cancer Bone Health May Help To Predict Myeloma Outcomes

August 14th 2018

A patient's bone health history may offer clues into their myeloma outcomes, according to a recent study.

Chemotherapy Versus Transplant: Comparing Quality of Life After Myeloma Treatment

August 9th 2018

Understanding these outcomes is important in planning treatments and mitigating the possibility of patients stopping their treatment.

When Cancer Clusters, Create a Medical Family Tree

July 28th 2018

Creating a medical family tree is helpful. If cancer is common, noting which branches include it can help inform decisions.

When to Treat Relapsed Myeloma

July 24th 2018

Here is what one expert says about the right time to start treating relapsed multiple myeloma.

Moving Mountains for Multiple Myeloma to Hike Through Iceland

July 23rd 2018

This hike marks the fifth continent to be visited by a Moving Mountains for Multiple Myeloma team

CURE Features First-Ever Social Media Takeover

July 13th 2018

The 'Right Track' to Navigate the Cancer Experience

July 9th 2018

Five leading cancer organizations came together to establish four steps that patients of all malignancies can turn to as they navigate their experience.

Moving Mountains

July 5th 2018

We spoke with two members of the Moving Mountains for Multiple Myeloma team.

Multiple Myeloma Research Foundation (MMRF) Receives Highest Rating from Charity Navigator for Exceptional Fiscal Management

June 20th 2018

MMRF Honored for Fifteenth Year for Outstanding Stewardship of Donors’ Funds

First Roundup Case Goes to Court, But the Jury Is Still Out on Whether it Causes Cancer

June 19th 2018

Dewayne Johnson is the first of hundreds of patients to take Monsanto to trial, claiming that Roundup caused them to get cancer. His case will be seen even sooner than others because in California dying plaintiffs can be given expedited trials.

FDA Approves Addition of Survival Data to Kyprolis Label for Multiple Myeloma Treatment

June 12th 2018

The Food and Drug Administration (FDA) approved the supplemental New Drug Application to add to the U.S. Prescribing Information for Kyprolis (carfilzomib) for the treatment of patients with relapsed or refractory multiple myeloma.

Patients With Myeloma Precursor Report Worse Quality of Life

June 8th 2018

Cancer affects many aspects of a person’s life, such as the overall quality of their day-to-day living, but what if a person didn’t have the full-blown disease already? Could a precursor or asymptomatic stage of the disease still burden them?

Two-Drug Combo Improves Post-Transplant Myeloma Outcomes

June 7th 2018

A two-drug regimen improved outcomes for patients with myeloma when given before a stem cell transplant.

A Time for Action

June 6th 2018

Researchers are considering whether some smoldering myelomas warrant treatment and which regimens are best.

Differences in Multiple Myeloma are Key to Treatment Options

May 31st 2018

When diagnosing patients with multiple myeloma, it is important to identify the specific stage, mutations and risk level of the disease to determine the most effective treatment method, according to Jeffrey Wolf, M.D.

Vitamin D Deficiencies Can Impact Myeloma Outcomes

May 30th 2018

A lack of vitamin D can have major impacts on myeloma treatment outomes.

CURE Honors Bone Health Champions

May 19th 2018

Four oncology nurses were recognized during the inaugural event for their efforts to prioritize the health of patients’ bone health during treatment.

CAR-T Cell Immunotherapy: Could it Be a Revolution in the Making?

May 19th 2018

It takes a lot to call something a revolution in medicine ... The most important, of course, is its impact on people’s lives — particularly, a cure for illness or a major extension of life. A revolution also implies a sweeping cataclysmic change, one that is disruptive and boldly states that things will no longer be the same.